Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fry

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Hospital (Rio De Janeiro, Brazil)|April 1, 1970
[Ampicillin potassium in the treatment of bacterial infections]W Fry
Western Journal of Medicine and Surgery|January 11, 2024
An Account of an Epidemic Bilious Fever, Which Prevailed in Indiana in 1845Thomas W Fry
Anti-Cancer Drug Design|July 11, 2000
Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancerD W Fry
Academy of Management Journal. Academy of Management|August 9, 1982
Technology-structure research: three critical issuesL W Fry
The Chicago Medical Journal|July 6, 2023
Cases in PracticeThos W Fry
Journal of the National Medical Association|August 13, 2003
Style watch: looking at the bigger pictureYvonne W Fry
Experimental Cell Research|March 22, 2003
Mechanism of action of erbB tyrosine kinase inhibitorsDavid W Fry
Ethnicity & Disease|October 14, 2003
Bacterial vaginosis and other maternal infections: treatable causes of the Black-White gap?Yvonne W Fry
Biochemical Pharmacology|November 1, 1990
Cytotoxic synergism between trimetrexate and etoposide. Evidence that trimetrexate potentiates etoposide-induced protein-associated DNA strand breaks in L1210 leukemia cells through alterations in intracellular ATP concentrationsD W Fry
Pharmacology & Therapeutics|August 24, 1999
Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitorsD W Fry
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Hospital (Rio De Janeiro, Brazil)|April 1, 1970
[Ampicillin potassium in the treatment of bacterial infections]W Fry
Western Journal of Medicine and Surgery|January 11, 2024
An Account of an Epidemic Bilious Fever, Which Prevailed in Indiana in 1845Thomas W Fry
Anti-Cancer Drug Design|July 11, 2000
Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancerD W Fry
Academy of Management Journal. Academy of Management|August 9, 1982
Technology-structure research: three critical issuesL W Fry
The Chicago Medical Journal|July 6, 2023
Cases in PracticeThos W Fry
Journal of the National Medical Association|August 13, 2003
Style watch: looking at the bigger pictureYvonne W Fry
Experimental Cell Research|March 22, 2003
Mechanism of action of erbB tyrosine kinase inhibitorsDavid W Fry
Ethnicity & Disease|October 14, 2003
Bacterial vaginosis and other maternal infections: treatable causes of the Black-White gap?Yvonne W Fry
Biochemical Pharmacology|November 1, 1990
Cytotoxic synergism between trimetrexate and etoposide. Evidence that trimetrexate potentiates etoposide-induced protein-associated DNA strand breaks in L1210 leukemia cells through alterations in intracellular ATP concentrationsD W Fry
Pharmacology & Therapeutics|August 24, 1999
Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitorsD W Fry
Pageof 21